Phase I study of induction chemotherapy and concomitant chemoradiotherapy with irinotecan, carboplatin, and paclitaxel for stage III non-small cell lung cancer. [electronic resource]
Producer: 20080116Description: 59-67 p. digitalISSN:- 1556-1380
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Agents -- administration & dosage
- Antineoplastic Agents, Phytogenic -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols
- Camptothecin -- administration & dosage
- Carboplatin -- administration & dosage
- Carcinoma, Non-Small-Cell Lung -- drug therapy
- Combined Modality Therapy
- Dose-Response Relationship, Drug
- Female
- Humans
- Irinotecan
- Lung Neoplasms -- drug therapy
- Male
- Middle Aged
- Neoplasm Staging
- Paclitaxel -- administration & dosage
- Survival Analysis
No physical items for this record
Publication Type: Clinical Trial, Phase I; Comparative Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.